A new study published in the Journal of Helminthology by researchers from the Estonian University of Life Sciences and the ...
Aardaia will use the new funding to expand its crop breeding platform and accelerate the development of the aardaker, a ...
Medical Device Network on MSN
Roche launches Axelios 1 sequencing platform
The launch was supported by collaborations with institutions such as the Hartwig Medical Foundation and Broad Clinical Labs.
MiDOG Animal Diagnostics, a leader in next-generation sequencing-based veterinary diagnostics, today announced the launch of MiDOG Parasite-Only Testing, a first-of-its-kind dedicated NGS-based ...
Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...
Healthcare Asia Magazine on MSN
Biomarkers market to top $112B by 2031 on drug discovery demand
Consumables held the largest share at 73.4% in 2025. The global biomarkers market is projected to grow to $112.1b by 2031, ...
Tec, Inc. (n6), the developer of icon96™, the first and only intelligent thermocycler platform with real-time, per-well ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by ...
Zacks Investment Research on MSN
Here's why you should add PacBio stock to your portfolio now
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product ...
The Minimal Residual Disease pipeline presents key opportunities for drug development, highlighting promising therapies in various trial phases. Companies like AmMax Bio and Genentech leverage ...
Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next-generation sequencing (NGS) technology in the field of precision oncology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results